Szot Matthew K 4
4 · Cadrenal Therapeutics, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Szot Matthew K
Chief Financial Officer
Transactions
- Award
Stock Options
2024-01-18+250,000→ 250,000 totalExercise: $0.94Exp: 2034-01-17→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.